Spironolactone and Breathing difficulty - from FDA reports


Summary

Breathing difficulty is found among people who take Spironolactone, especially for people who are female, 60+ old , have been taking the drug for < 1 month, also take medication Furosemide, and have Primary pulmonary hypertension . We study 41,237 people who have side effects while taking Spironolactone from FDA. Among them, 3,235 have Breathing difficulty. Find out below who they are, when they have Breathing difficulty and more.

What to expect?

If you take Spironolactone and have Breathing difficulty, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Spironolactone and have Breathing difficulty

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Spironolactone

Spironolactone has active ingredients of spironolactone. It is often used in acne. (latest outcomes from Spironolactone 43,283 users)

Breathing Difficulty

Breathing difficulty has been reported by people with high blood pressure, chronic obstructive pulmonary disease, asthma, primary pulmonary hypertension, rheumatoid arthritis (latest reports from 283,984 Breathing difficulty patients).

On Jan, 30, 2017

41,237 people reported to have side effects when taking Spironolactone.
Among them, 3,235 people (7.84%) have Breathing Difficulty


Number of reports submitted per year:

Could Spironolactone cause Breathing difficulty?

Time on Spironolactone when people have Breathing Difficulty *:

  • < 1 month: 33.85 %
  • 1 - 6 months: 11.54 %
  • 6 - 12 months: 20.77 %
  • 1 - 2 years: 11.54 %
  • 2 - 5 years: 16.15 %
  • 5 - 10 years: 5.38 %
  • 10+ years: 0.77 %

Gender of people who have Breathing Difficulty when taking Spironolactone *:

  • female: 57.97 %
  • male: 42.03 %

Age of people who have Breathing Difficulty when taking Spironolactone *:

  • 0-1: 0.89 %
  • 2-9: 0.59 %
  • 10-19: 1.04 %
  • 20-29: 3.04 %
  • 30-39: 3.71 %
  • 40-49: 9.08 %
  • 50-59: 20.42 %
  • 60+: 60.93 %

Top conditions involved for these people *:

  • Primary Pulmonary Hypertension (458 people, 14.16%)
  • High Blood Pressure (328 people, 10.14%)
  • Pulmonary Hypertension (224 people, 6.92%)
  • Chronic Obstructive Pulmonary Disease (169 people, 5.22%)
  • Pain (150 people, 4.64%)

Top co-used drugs for these people *:

  • Furosemide (762 people, 23.55%)
  • Lasix (731 people, 22.60%)
  • Digoxin (561 people, 17.34%)
  • Aspirin (490 people, 15.15%)
  • Coumadin (399 people, 12.33%)

Top other side effects for these people *:

  • Fatigue (647 people, 20.00%)
  • Chest Pain (540 people, 16.69%)
  • Weakness (531 people, 16.41%)
  • Oedema Peripheral (463 people, 14.31%)
  • Nausea (463 people, 14.31%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Breathing difficulty when taking Spironolactone?

Browse all side effects of Spironolactone

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Breathing difficulty

Breathing difficulty

Could your condition cause Breathing difficulty

Breathing difficulty

Related studies

Can you answer these questions?

More questions for: Spironolactone, Breathing difficulty

You may be interested in these reviews

More reviews for: Spironolactone, Breathing difficulty